TFX-30087-03065 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-11-16
Dose 1 — Pfizer-BioNTech
2021-12-07
Dose 2 — Pfizer-BioNTech
2022-09-23
Registered in v-safe
2022-12-07
Survey response — 12 months, dose 2, dependent
MedDRA: Loss of personal independence in daily activities, Otitis externa, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: 10/28/2022 left school early with fever 104; swimmer's ear infection 11/12/2022

MedDRA releases: 2024-11 · check-in free text available
2022-12-07
Report sent to call center — 12 months, dose 2, dependent
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-12-08
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-11-16	Pfizer-BioNTech	No
2	2021-12-07	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-12-07	Unsuccessful

Free text

Release 12 — 12 months, dose 2, dependent

2022-12-07

Symptoms: 10/28/2022 left school early with fever 104; swimmer's ear infection 11/12/2022

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Loss of personal independence in daily activities	·	·	✓
SD	Otitis externa	·	·	✓
SD	Pyrexia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release